TRIO Pharmaceuticals (Pre-Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- June 08, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $3,100,000
Company Info
- Company Description
- TRIO Pharmaceuticals is a biotechnology company pioneering bispecific antibodies for the treatment of cancer with unprecedented potency and selectivity. TRIO's innovative antibody drugs directly stop tumor growth without affecting normal cells and selectively stop immunosuppression in the tumor without targeting the current immune checkpoint pathways.
- Market
- Cancer treatment
- Location
- San Diego, CA, USA
- Coinvestors
- Multiple Myeloma Research Foundation, NuFund Venture Group, Life Science Angels